Mirae Asset Capital Life Science, Inc., Mirae Asset Venture Investments
VC · New York (United States)
Sign up free to access full profile and submit your pitch.
About
Mirae Asset Capital Life Science, Inc. is a venture capital firm specializing in growth capital, series A, series B, series C, and seed investments. The firm allocates 50% of its capital for investments in series A, 25% for series B, 15% for series C and 10% for seed investments. It prefers to invest in biotechnology, therapeutics (modality agnostic), drug development, clinical data, market dynamics, oncology, immunology, CV/metabolic, CNS/ophthalmology, rare/genetic disease, digital health, AI/ML tools, quantum computing, generative biology/chemistry, occupational therapy services, combinatorial chemistry and other lead generating technologies, diagnostics (opportunistic), life science and healthcare sectors. The firm seeks to invest in the U.S. (primary) and Europe/Canada (opportunistic). The firm also so-invests with life science investors. The firm seeks to invest up to $10 million in companies. The firm was founded in 2023 and is based in New York, New York with additional offices in San Francisco, California; Menlo Park, California and Boston, Massachusetts. Mirae Asset Capital Life Science, Inc. is a joint venture between Mirae Asset Capital and Mirae Asset Global Investments.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
Co-Investors of Mirae Asset Capital Life Science, Inc., Mirae Asset Venture Investments
Other investors that have backed the same portfolio companies as Mirae Asset Capital Life Science, Inc., Mirae Asset Venture Investments. Expand any entry to see the shared portfolio companies.
No co-investment overlap on record for Mirae Asset Capital Life Science, Inc., Mirae Asset Venture Investments yet.
